Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Validating self-reported cervical cancer screening among women leaving jails.

Webb S, Kelly PJ, Wickliffe J, Ault K, Ramaswamy M.

PLoS One. 2019 Jul 1;14(7):e0219178. doi: 10.1371/journal.pone.0219178. eCollection 2019.

2.

Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.

Chamberlain AT, Limaye RJ, O'Leary ST, Frew PM, Brewer SE, Spina CI, Ellingson MK, Dudley MZ, Orenstein WA, Donnelly MA, Riley LE, Ault KA, Salmon DA, Omer SB.

Vaccine. 2019 May 1;37(19):2532-2536. doi: 10.1016/j.vaccine.2019.03.005. Epub 2019 Apr 5.

PMID:
30962093
3.

Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.

Munoz FM, Jackson LA, Swamy GK, Edwards KM, Frey SE, Stephens I, Ault K, Winokur P, Petrie CR, Wolff M, Patel SM, Keitel WA.

Vaccine. 2018 Dec 18;36(52):8054-8061. doi: 10.1016/j.vaccine.2018.10.088. Epub 2018 Nov 8.

PMID:
30416018
4.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
5.

Human Papillomavirus Vaccine Knowledge and Intention Among Adult Inmates in Kansas, 2016-2017.

Allison M, Musser B, Satterwhite C, Ault K, Kelly P, Ramaswamy M.

Am J Public Health. 2018 Aug;108(8):1000-1002. doi: 10.2105/AJPH.2018.304499. Epub 2018 Jun 21.

6.

Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings.

Frew PM, Randall LA, Malik F, Limaye RJ, Wilson A, O'Leary ST, Salmon D, Donnelly M, Ault K, Dudley MZ, Fenimore VL, Omer SB.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1548-1557. doi: 10.1080/21645515.2018.1425116. Epub 2018 Feb 15.

7.

Response to Donahue et al. 2017 in press article.

Ault KA, Riley LE.

Vaccine. 2018 Apr 19;36(17):2230. doi: 10.1016/j.vaccine.2017.12.031. Epub 2018 Jan 3. No abstract available.

PMID:
29306504
8.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.

Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, Muñoz N, Myers E, Paavonen J, Pitisuttihum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Papillomavirus Res. 2016 Dec;2:61-69. doi: 10.1016/j.pvr.2016.03.002. Epub 2016 Mar 14.

9.

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A.

Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5.

PMID:
28886907
10.

Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial.

Kriss JL, Frew PM, Cortes M, Malik FA, Chamberlain AT, Seib K, Flowers L, Ault KA, Howards PP, Orenstein WA, Omer SB.

Vaccine. 2017 Mar 13;35(11):1551-1558. doi: 10.1016/j.vaccine.2017.01.037. Epub 2017 Feb 16.

11.

Containment of transgenic trees by suppression of LEAFY.

Klocko AL, Brunner AM, Huang J, Meilan R, Lu H, Ma C, Morel A, Zhao D, Ault K, Dow M, Howe G, Shevchenko O, Strauss SH.

Nat Biotechnol. 2016 Sep 8;34(9):918-22. doi: 10.1038/nbt.3636. No abstract available.

PMID:
27606454
12.

Impact of a multi-component antenatal vaccine promotion package on improving knowledge, attitudes and beliefs about influenza and Tdap vaccination during pregnancy.

Chamberlain AT, Seib K, Ault KA, Rosenberg ES, Frew PM, Cortes M, Whitney EA, Berkelman RL, Orenstein WA, Omer SB.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2017-2024. Epub 2016 Apr 15.

13.

Trends in reasons for non-receipt of influenza vaccination during pregnancy in Georgia, 2004-2011.

Chamberlain AT, Berkelman RL, Ault KA, Rosenberg ES, Orenstein WA, Omer SB.

Vaccine. 2016 Mar 18;34(13):1597-1603. doi: 10.1016/j.vaccine.2016.01.058. Epub 2016 Feb 6.

14.

Reply.

Bednarczyk RA, Figueroa-Downing D, Ault K.

Am J Obstet Gynecol. 2016 May;214(5):667-8. doi: 10.1016/j.ajog.2015.12.059. Epub 2016 Jan 6. No abstract available.

PMID:
26767793
15.

Cervical Cancer Screening in the United States-Affiliated Pacific Islands: Options and Opportunities.

Waxman AG, Buenconsejo-Lum LE, Cremer M, Feldman S, Ault KA, Cain JM, Diaz ML; Expert Panel on Cervical Cancer Screening in the US Territories Pacific Island Jurisdictions.

J Low Genit Tract Dis. 2016 Jan;20(1):97-104. doi: 10.1097/LGT.0000000000000161.

16.

Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men.

Rosen T, Nelson A, Ault K.

Cutis. 2015 Oct;96(4):277-82.

PMID:
26682290
17.

The Expanded Impact of Human Papillomavirus Vaccine.

Pahud BA, Ault KA.

Infect Dis Clin North Am. 2015 Dec;29(4):715-24. doi: 10.1016/j.idc.2015.07.007. Review.

PMID:
26610422
18.

Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?

Bednarczyk RA, Figueroa-Downing D, Ault K.

Am J Obstet Gynecol. 2016 Apr;214(4):490-493. doi: 10.1016/j.ajog.2015.10.920. Epub 2015 Oct 31. No abstract available.

19.

Adolescents' Assessments of the Helpfulness of Treatment for Major Depression: Results From a National Survey.

Edlund MJ, Pettiford AG, Hampton J, Forman-Hoffman VL, Ault KL, Colpe LJ, Hedden SL.

Psychiatr Serv. 2015 Oct;66(10):1064-73. doi: 10.1176/appi.ps.201400018. Epub 2015 Jun 15.

PMID:
26073408
20.

Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season.

Chamberlain AT, Seib K, Ault KA, Rosenberg ES, Frew PM, Cortés M, Whitney EA, Berkelman RL, Orenstein WA, Omer SB.

Vaccine. 2015 Jul 9;33(30):3571-9. doi: 10.1016/j.vaccine.2015.05.048. Epub 2015 Jun 1.

21.

Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy: A Focus on Vaccine Hesitancy and Perceptions of Disease Severity and Vaccine Safety.

Chamberlain AT, Seib K, Ault KA, Orenstein WA, Frew PM, Malik F, Cortés M, Cota P, Whitney EA, Flowers LC, Berkelman RL, Omer SB.

PLoS Curr. 2015 Feb 25;7. pii: ecurrents.outbreaks.d37b61bceebae5a7a06d40a301cfa819. doi: 10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819.

22.

Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions.

Saftlas AF, Spracklen CN, Ryckman KK, Stockdale CK, Penrose K, Ault K, Rubenstein LM, Pinto LA.

J Reprod Immunol. 2015 Jun;109:74-83. doi: 10.1016/j.jri.2015.01.002. Epub 2015 Jan 30.

PMID:
25721621
23.

Disability status, mortality, and leading causes of death in the United States community population.

Forman-Hoffman VL, Ault KL, Anderson WL, Weiner JM, Stevens A, Campbell VA, Armour BS.

Med Care. 2015 Apr;53(4):346-54. doi: 10.1097/MLR.0000000000000321.

24.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

Gynecol Oncol. 2015 Feb;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. Epub 2015 Jan 8.

PMID:
25579107
25.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

J Low Genit Tract Dis. 2015 Apr;19(2):91-6. doi: 10.1097/LGT.0000000000000103.

PMID:
25574659
26.

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH.

Obstet Gynecol. 2015 Feb;125(2):330-7. doi: 10.1097/AOG.0000000000000669.

PMID:
25569009
27.

Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices.

Frew PM, Saint-Victor DS, Isaacs MB, Kim S, Swamy GK, Sheffield JS, Edwards KM, Villafana T, Kamagate O, Ault K.

Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S400-7. doi: 10.1093/cid/ciu726.

28.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410.

29.

Women's health providers as vaccine providers in public health emergencies.

Van Otterloo J, Seib K, Ault KA, Omer SB.

J Reprod Med. 2014 Jul-Aug;59(7-8):401-8.

PMID:
25098031
30.

"Doctor, it hurts…".

Ault KA.

Obstet Gynecol. 2014 Feb;123(2 Pt 1):223-4. doi: 10.1097/AOG.0000000000000119. No abstract available.

PMID:
24402604
31.

Research on vaccines during pregnancy: protocol design and assessment of safety.

Munoz FM, Sheffield JS, Beigi RH, Read JS, Swamy GK, Jevaji I, Rasmussen SA, Edwards KM, Fortner KB, Patel SM, Spong CY, Ault K, Heine RP, Nesin M.

Vaccine. 2013 Sep 13;31(40):4274-9. doi: 10.1016/j.vaccine.2013.07.042. Epub 2013 Jul 29.

PMID:
23906888
32.

Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.

Sheffield JS, Munoz FM, Beigi RH, Rasmussen SA, Edwards KM, Read JS, Heine RP, Ault KA, Swamy GK, Jevaji I, Spong CY, Fortner KB, Patel SM, Nesin M.

Vaccine. 2013 Sep 13;31(40):4264-73. doi: 10.1016/j.vaccine.2013.07.031. Epub 2013 Jul 29.

PMID:
23906887
33.

Beyond likes and tweets: an in-depth look at the physician social media landscape.

Fogelson NS, Rubin ZA, Ault KA.

Clin Obstet Gynecol. 2013 Sep;56(3):495-508. doi: 10.1097/GRF.0b013e31829e7638.

PMID:
23835911
34.

Human papillomavirus vaccination: current indications and future directions.

Gattoc L, Nair N, Ault K.

Obstet Gynecol Clin North Am. 2013 Jun;40(2):177-97. doi: 10.1016/j.ogc.2013.03.007. Epub 2013 May 10.

35.

Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth.

Richards JL, Hansen C, Bredfeldt C, Bednarczyk RA, Steinhoff MC, Adjaye-Gbewonyo D, Ault K, Gallagher M, Orenstein W, Davis RL, Omer SB.

Clin Infect Dis. 2013 May;56(9):1216-22. doi: 10.1093/cid/cit045. Epub 2013 Feb 1.

36.

Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.

Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB.

Pediatrics. 2012 Nov;130(5):798-805. doi: 10.1542/peds.2012-1516. Epub 2012 Oct 15.

PMID:
23071201
37.

Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women.

Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, Forney LJ, Carlton JM, Abdo Z, Ravel J.

Sex Transm Dis. 2012 Oct;39(10):807-12.

38.

Programmatic and research priorities for improving influenza immunization of pregnant women.

Ault KA, Heine RP, Riley LE.

Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S75-7. doi: 10.1016/j.ajog.2012.06.078. Epub 2012 Jul 9. Review.

PMID:
22920064
39.

Genetic comparison of water molds from embryos of amphibians Rana cascadae, Bufo boreas and Pseudacris regilla.

Ault KK, Johnson JE, Pinkart HC, Wagner RS.

Dis Aquat Organ. 2012 Jun 13;99(2):127-37. doi: 10.3354/dao02456.

40.

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.

Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM; FUTURE I and II Study Group.

BMJ. 2012 Mar 27;344:e1401. doi: 10.1136/bmj.e1401.

41.

Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections.

Wiley DJ, Masongsong EV, Lu S, Heather L S, Salem B, Giuliano AR, Ault KA, Haupt RM, Brown DR.

Cancer Epidemiol. 2012 Jun;36(3):e183-9. doi: 10.1016/j.canep.2011.12.007. Epub 2012 Jan 25.

PMID:
22277329
42.

Missed opportunities: a national survey of obstetricians about attitudes on maternal and infant immunization.

Link-Gelles R, Chamberlain AT, Schulkin J, Ault K, Whitney E, Seib K, Omer SB.

Matern Child Health J. 2012 Dec;16(9):1743-7. doi: 10.1007/s10995-011-0936-0.

PMID:
22198260
43.

Cervical cancer prevention: better tests, better tools, and more equitable outcomes.

Ault KA.

J Natl Cancer Inst. 2011 Sep 21;103(18):1352-3. doi: 10.1093/jnci/djr330. Epub 2011 Sep 6. No abstract available.

PMID:
21900118
44.

Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.

Baker DA, Ferris DG, Martens MG, Fife KH, Tyring SK, Edwards L, Nelson A, Ault K, Trofatter KF, Liu T, Levy S, Wu J.

Infect Dis Obstet Gynecol. 2011;2011:806105. doi: 10.1155/2011/806105. Epub 2011 Aug 24.

45.

Relevant factors to consider prior to an investor-owned acquisition of a nonprofit healthcare entity.

Ault K, Childs B, Wainright CF, Young M.

J Healthc Manag. 2011 Jul-Aug;56(4):269-80; discussion 280-1.

PMID:
21838025
46.

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.

Castellsagué X, Muñoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A.

Br J Cancer. 2011 Jun 28;105(1):28-37. doi: 10.1038/bjc.2011.185. Epub 2011 May 31.

47.

Advancing human papillomavirus research with a rhesus monkey model.

Ault KA, Brown DR.

J Natl Cancer Inst. 2011 May 4;103(9):703. doi: 10.1093/jnci/djr125. Epub 2011 Apr 11. No abstract available.

PMID:
21483022
48.

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia.

Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J; FUTURE I and II Study Group.

Sex Transm Infect. 2011 Aug;87(5):372-6. doi: 10.1136/sti.2010.044354. Epub 2011 Apr 6.

49.

Barriers to cervical cancer screening in Mulanje, Malawi: a qualitative study.

Fort VK, Makin MS, Siegler AJ, Ault K, Rochat R.

Patient Prefer Adherence. 2011 Mar 14;5:125-31. doi: 10.2147/PPA.S17317.

50.

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.

Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Majewski S, Muñoz N, Sings HL, Harkins K, Rutkowski MA, Haupt RM, Garner EI; FUTURE I and II Study Group.

Int J Cancer. 2011 Mar 15;128(6):1344-53. doi: 10.1002/ijc.25723. Epub 2011 Jan 12.

Supplemental Content

Support Center